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Abstract
Background: Androgen signalling is essential both for male development and function of the male reproductive
system in adulthood. Within the adult testis, Germ cells (GC) do not express androgen receptor (AR) suggesting
androgen-mediated promotion of spermatogenesis must act via AR-expressing somatic cell-types. Several recent
studies have exploited the Cre/lox system of conditional gene-targeting to ablate AR function from key somatic
cell-types in order to establish the cell-specific role of AR in promotion of male fertility. In this study, we have used
a similar approach to specifically ablate AR-signalling from Vascular Endothelial (VE) cells, with a view to defining
the significance of androgen signalling within this cell-type on spermatogenesis.
Findings: AR expression in VE cells of the testicular vasculature was confirmed using an antibody against AR. A
Cre-inducible fluorescent reporter line was used to empirically establish the utility of a mouse line expressing Cre
Recombinase driven by the Tie2-Promoter, for targeting VE cells. Immunofluorescent detection revealed expression
of YFP (and therefore Cre Recombinase function) limited to VE cells and an interstitial population of cells, believed
to be macrophages, that did not express AR. Mating of Tie2-Cre males to females carrying a floxed AR gene
produced Vascular Endothelial Androgen Receptor Knockout (VEARKO) mice and littermate controls. Ablation of AR
from all VE cells was confirmed; however, no significant differences in bodyweight or reproductive tissue weights
could be detected in VEARKO animals and spermatogenesis and fertility was unaffected.
Conclusions: We demonstrate the successful generation and empirical validation of a cell-specific knockout of AR
from VE cells, and conclude that AR expression in VE cells is not essential for spermatogenesis or male fertility.
Background
Androgens, produced by the testicular Leydig cells (LC),
act as essential regulators of both the development of
the male reproductive system and the initiation and
maintenance of spermatogenesis in postnatal life
(reviewed in [1,2]). Androgens bind to the androgen
receptor (AR), a member of the nuclear hormone recep-
tor transcription factor superfamily, to modulate gene
transcription in target cells [3]. In the adult testis, Germ
cells (GC), do not express AR, and GCs lacking a func-
tional AR mature normally [4], consequently, androgens
are believed to regulate spermatogenesis via androgen-
AR signalling in AR-expressing testicular somatic cells.
Recent exploitation of the Cre/lox system of conditional
gene-targeting has elucidated the cell-specific role of AR
in several key cell-types of the testis including Sertoli
cells (SC) [5,6], LCs [7], GCs [8], Peritubular myoid cells
(PTM) [9] and vascular smooth muscle cells (VSM) [10].
A further cell-type expressing AR and consequently
responsive to androgen signalling are the vascular
endothelial (VE) cells [11]. VE cells line the interior wall
(Tunica Intima) of all vessels of the circulatory system.
VE cells possess an anti-thrombotic surface which facili-
tates laminar blood flow, whilst permitting nutrients and
macromolecules to flow out of the bloodstream through
intercellular spaces, the resu l to fe n d o t h e l i a lc e l lc o n -
traction or active transport through the cells themselves
by transcytosis. The endothelium also regulates angio-
genesis, vasoregulation, and leucocyte trafficking into
sites of injury during inflammatory responses (for review
see [12]).
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the presence of AR within testicular VE cells, with stu-
dies arguing both for and against AR expression [13-15].
Given the wide-ranging impact of VE function on both
the vascular system and peripheral organs, expression of
AR within VE cells of the testicular blood vessels would
raise the possibility that androgen-mediated modulation
of endothelial cell function within the testis contributes
to the regulation of spermatogenesis. To address this we
first sought to unequivocally establish whether testicular
VE cells express AR in vivo. We then exploited a condi-
tional gene targeting approach to specifically ablate AR
from endothelial cells of the vascular system to examine
the impact of perturbed endothelial AR-signalling on
spermatogenesis and male fertility.
Findings
Localisation of AR expression in the testicular vasculature
To confirm that vascular endothelial (VE) cells of the
testicular vasculature express AR, immunofluorescent
detection of AR was performed on sections of testis
taken from control adult animals (n = 3). Nuclear AR
expression was confirmed within all smooth muscle
cells of the vasculature as previously described [10]. In
addition, AR localised to the nucleus of approximately
fifty percent of testicular VE cells (Figure 1a).
Empirical validation of a VE-specific Cre Recombinase
mouse line
In order to specifically target AR in VE cells, a mouse
line carrying a Cre Recombinase transgene driven by the
promoter of the endothelial-specific angiopoietin recep-
tor Tie2 was exploited [16]. To empirically establish the
specificity of Cre Recombinase expression, (an essential
requirement prior to any conditional gene-targeting
experiment [17]), heterozygous Tie2-Cre males were
mated to homozygous R26EYFPR females [18] and
testes from offspring examined at adulthood. Expression
of YFP was detected only in offspring inheriting the
Tie2-Cre transgene (n = 3 per genotype). Within the
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Figure 1 A: Immunofluorescence detection localises AR to all smooth muscle cells of testicular blood vessels (arrow) and
approximately 50% of vascular endothelial cells (solid arrowhead). AR is not detected in the remaining endothelial cells (outline
arrowhead). Non-specific staining of arteriole elastic fibres occurs in even the absence of primary antibody (inset, arrow). B: Colocalisation of YFP
immunofluorescence with the specific endothelial marker CD31 demonstrates that Tie2-Cre is active in endothelial cells of the testicular blood
vessels (arrows). Tie2-Cre is also active in a proportion of testicular interstitial cells (arrowhead) C: Double immunofluorescence staining for AR
and YFP demonstrates colocalisation of AR and YFP in a proportion of testicular vascular endothelial cells (arrowheads). D: YFP-expressing
interstitial cells do not express AR (arrows). Scale bars are 20 μm.
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VE cells of the blood vessel Tunica Intima (Figure 1b);
however, a further population of interstitial cells also
expressed YFP. Previous studies suggest these interstitial
cells are likely to be macrophages which arise along
with endothelial cells from a common Tie2-expressing
progenitor population [19,20]. Double immunofluores-
cent analysis on adult testis sections (n = 3) using anti-
bodies directed against AR and YFP clearly
demonstrated that a proportion of the YFP-positive VE
cells were also AR-positive (Figure 1c) but that YFP-
positive interstitial cells do not express AR (Figure 1d);
we therefore concluded that, although we would be
deleting AR in both populations, the Tie2-Cre line had
utility for specific ablation of AR-function in the Vascu-
lar Endothelium. Furthermore, no significant difference
in bodyweight or seminal vesicle weight could be
detected and spermatogenesis was confirmed to be nor-
mal in Tie2-Cre:R26YFPR animals (data not shown),
demonstrating that the presence of the Cre Recombi-
nase transgene did not itself induce a phenotype.
Generation of VEARKO mice
To generate Vascular Endothelial Androgen Receptor
Knock-Out (VEARKO) mice and littermate controls,
heterozygous Tie2-Cre males were mated to homozy-
gous ARflox [5] females. Offspring were genotyped by
PCR to establish inheritance of the Tie2-Cre transgene
(Figure 2a).
PCR interrogation of genomic DNA extracted from
testes of VEARKO mice confirmed ablation of AR from
a subset of testicular cells (Figure 2b). No ablation was
detected in littermate control testes (n = 5 per geno-
type). Immunofluorescent detection of AR protein on
testis sections from VEARKO animals confirmed that
ablation of normal AR-signalling within the testis was
limited to VE cells, with AR ablated from all VE cells
examined (n = 3) (Figure 2d). AR expression was
retained in control littermates (n = 3).
Phenotypic analysis of VEARKO mice
Comparison of bodyweight, seminal vesicle (SV) weight,
and anogenital distance (a marker of androgen action
c     Control d    VEARKO
AR  Counterstain
Control VEARKO ARKO a b Control VEARKO NTC
Figure 2 A: VEARKO mice can be separated from controls through PCR interrogation of inheritance of Cre Recombinase.3 2 4b p
amplicon = internal positive control. 102 bp amplicon = Cre Recombinase. NTC = no-template control. B: PCR amplification of AR using primers
spanning the floxed exon 2 on genomic DNA isolated from VEARKO and control testes demonstrates that a proportion of cells in the testes of
VEARKO mice contain a recombined AR (612 bp). No recombination is observed in testes from control animals. Testes from total-ARKO mice,
which demonstrate 100% recombination of AR, are included for comparison. C: AR expression is observed in endothelial cells of testicular blood
vessels from Control mice (arrows); D: Conversely, no endothelial cells in testicular blood vessels of VEARKO mice express AR (arrowheads). Scale
bars are 20 μm.
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revealed no significant difference between VEARKO
males and controls (table 1) when examined in adult-
hood (postnatal day 57) (n = 3 per genotype); testes
were fully descended into the scrotum.
Gross phenotypic analysis revealed no significant dif-
ference in testis weight between VEARKO mice and
controls in adulthood (Figure 3a). Blind-scoring of testi-
cular sections from VEARKO and control mice (n = 5
per genotype) identified no phenotypic differences in
testicular architecture with all stages of spermatogenesis
present (Figure 3b-e) and morphologically mature sper-
matozoa detected in the cauda epididymis (Figure 3f-g).
To determine fertility status, seven VEARKO males and
five littermate controls were each housed individually
with a 129SV/C57BL/6 JF1 female for five days. No sig-
nificant difference was observed either in mating success
(production of pups), or in average litter size. All seven
VEARKO males and four of five control males sired
pups with an average litter size of 7.857 ± 0.3401 (n =
7) and 8.250 ± 0.4787 (n = 4) respectively.
Discussion
The testicular vasculature is known to be an important
regulator of both testis development [20,22] and function
[10]. The vascular endothelium which lines every blood
vessel of the circulatory system and controls nutrient,
macromolecule and immune cell entry into peripheral
tissues, acts as an important regulator of the testicular
micro-environment, and is known to respond to sex ster-
oid hormone stimulation (for reviews see [23-25]). We
have demonstrated that VE cells of the testicular vascular
system express AR in vivo and thus are responsive to
androgen-stimulation. However, surprisingly, AR expres-
sion was limited to approximately fifty percent of VE
cells. Whether this represents two different functional
populations of VE cells, a ‘snap-shot’ of AR expression
cycling in all VE cells, or a response by certain cells to a
specific localised signal requires further investigation.
Empirical validation of Cre Recombinase expression in
the Tie2-Cre line provides a good example of why such
validation is necessary (reviewed in [17]). Whilst we pre-
dicted VE expression of Cre Recombinase, further
expression in an interstitial population of cells was unex-
pected. Based upon previous characterisation of the Tie2-
Cre line, these cells are likely to be macrophages [19,20]
which are known to physically localise in close proximity
to AR-expressing Leydig Cells. Consequently the Tie2-
C r el i n ei sl i k e l yt oh a v ef u r t h e ru t i l i t ya sat e s t i c u l a r
macrophage-targeting Cre Recombinase, this requires
further empirical validation. For this study, however, the
absence of detectable AR expression in these interstitial
c e l l sc o n f i r m e dt h a tt h eT i e 2 - C r el i n eh a du t i l i t yf o r
ablating AR expression specifically from VE cells.
A combination of genomic PCR and immunofluores-
cent localisation confirmed specific AR ablation from
the VE cells of the testis in VEARKO mice. However,
unlike our previous study targeting AR in the smooth
muscle cells of the testicular vasculature [10], we
observed no significant difference in testis weight, semi-
nal vesicle weight (a surrogate marker of circulating tes-
tosterone concentration), or any impact on
spermatogenesis or fertility in VEARKO mice. We can-
n o tr u l eo u tar o l ef o rV E - A Re x p r e s s i o ni na s p e c t so f
testicular function other than support of spermatogen-
esis, however completion of spermatogenesis also
requires production of androgens by normally function-
ing Leydig cells [26], and thus were there to be an
impact on steroidogenesis, completion of spermatogen-
esis allows us to infer that this is also likely to be rela-
tively minor. This requires further investigation.
Nevertheless, this focused study unequivocally demon-
strates successful generation of a mouse model lacking
AR-signalling in VE cells of the circulatory system and
confirms that AR-signalling via VE cells is not an essen-
tial requirement for spermatogenesis and male fertility.
Methods
Production of VEARKO and YFP reporter mice
Mice in which the AR has been selectively ablated from
VE cells were generated using Cre/loxP technology.
Male congenic C57BL/6 J carrying a random insertion
of Tie2-Cre [16] were mated to C57BL/6 J female mice
homozygous for a floxed AR [5]. The +/Cre, ARflox/y
male offspring from these matings were termed
‘VEARKO’, whereas the +/+, ARflox/y littermates were
used as controls, termed ‘control’. A Cre-inducible yel-
low fluorescent protein (YFP) reporter line used to
document the expression of the Tie2-Cre transgene was
generated by mating Tie-Cre males to female mice
homozygous for a YFP transgene inserted into the
Rosa26 locus [18]. Sex and genotype ratios were all
identified at the expected Mendelian ratios. The study
was approved by The University of Edinburgh Ethics
Committee and conducted under licensed approval from
the UK Home Office (PPL: 60/3544).
Fertility testing
Eight week old VEARKO male mice (n = 7) and litter-
mate controls (n = 5) were singly housed with 129SV/
Table 1 Adult VEARKO mice have normal body weight,
AGD and SV weight
Control VEARKO
Body weight 24.2 ± 0.1 g 25.0 ± 1.0 g
AGD 15.6 ± 0.4 mm 15.5 ± 0.5 mm
SV weight 0.21 ± 0.0047 g 0.21 ± 0.0067 g
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culled by inhalation of carbon dioxide and subsequent
cervical dislocation, and fetuses counted ten days later.
Recovery of reproductive tissues
Male mice were culled at post-natal day (d) 57 by inha-
lation of carbon dioxide and subsequent cervical disloca-
tion. Body weight and anogenital distance were
measured and mice were examined for any gross
abnormalities of the reproductive system. Testes and SV
were removed and weighed. Tissues were fixed in
Bouin’s fixative (Clin-Tech, Guildford, UK) for 6 h.
Bouin’s-fixed tissues were processed and embedded in
paraffin wax, and 5-μm sections were used for histologi-
cal analysis as reported previously [9]. Sections of testis
were stained with hematoxylin and eosin using standard
protocols and examined for histological abnormalities.
Immunohistochemistry
Single immunofluorescent staining for AR (Santa Cruz sc-
816) was performed on VEARKO and littermate controls
and double fluorescent staining for AR/YFP (Abcam
ab38689) or YFP/CD31 (Abcam ab28364) was performed
on YFP reporter mice. Sections were deparaffinized and
rehydrated, and high-pressure antigen retrieval was per-
formed in 0.01 M pH6 citrate buffer for 5 min. Endogen-
ous peroxidase was blocked using 3% hydrogen peroxide
in methanol and non-specific antibody binding sites were
blocked with a mixture of 20% normal goat serum/80%
tris-buffered saline/5% bovine serum albumin (NGS/TBS/
BSA). Sections were incubated overnight at 4°C with the
primary antibody diluted in NGS/TBS/BSA. Immunostain-
ing was detected using the appropriate secondary antibody
(Goat anti-rabbit peroxidase (Dako P0448), or Goat anti-
mouse peroxidase (Dako P0447)) diluted 1:200 in NGS/
TBS/BSA incubated for one hour at room temperature,
then fluorescein Tyramide Signal Amplification system
(’TSA™’, Perkin Elmer) diluted 1:50 in its own buffer to
manufacturers instructions for 10 min at room tempera-
ture. If a second primary antibody was used, the process
was then repeated from the peroxidase block onwards
with the appropriate conditions and detection for the sec-
ond antibody and use of Cyanine - 5 TSA™ for a different
fluorescent wavelength to distinguish between the two
antibodies. Slides were counterstained with propidium
iodide (Sigma, UK, #P4170) and mounted with
Figure 3 A: Testis weight does not differ between control and VEARKO mice. B-E: Spermatogenesis is normal in both Control and VEARKO
testes, with all spermatogenic stages identified. F, G: morphologically mature spermatozoa are present in the cauda epididymides of both
control and VEARKO animals (asterisks). Scale bars are 100 μm.
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Images were captured using a LSM 710 confocal micro-
scope (Zeiss) with Zen software. A minimum of three
mice of each genotype were used and sections from
VEARKO and control littermates were processed in paral-
lel on the same slide, on at least two separate occasions.
Appropriate negative controls were included to ensure
that any staining observed was specific.
PCR genotyping of mice
Mice were genotyped for inheritance of Cre Recombi-
nase as previously described [9]. PCR amplification pro-
ducts were resolved using a QiaXcel capillary system
(Qiagen, UK). An amplicon of 324 bp acted as a positive
internal control whilst an amplicon of 102 bp indicated
inheritance of the Cre Recombinase transgene.
Determination of genomic ablation of AR
DNA was isolated from a piece of frozen testis using a
Mouse tail genomic DNA kit (Gen-Probe Life Sciences
Ltd, UK) according to the manufacturer’s instructions
and subjected to PCR amplification using primers
GCTGATCATAGGCCTCTCTC and TGCCCTGAAA
GCAGTCCTCT and Biomix Red Taq polymerase PCR
kit (Bioline, UK). PCR amplification products were
resolved using a QiaXcel capillary system (Qiagen, UK).
An amplicon of 1142 bp indicated presence of a floxed
AR whilst an amplicon of 612 bp indicated recombina-
tion between loxP sites and deletion of AR exon 2.
Statistical analysis
Statistical analyses of weights, AGD and fertility testing
were carried out in GraphPad Prism (version 5; Graph-
Pad Software Inc., San Diego, CA, USA) using a 2-tailed
unpaired t test.
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